Drug Information

Drug General Information
Drug ID
D0L7VC
Former ID
DNCL002225
Drug Name
GI-6207
Indication Metastatic medullary thyroid cancer [ICD9: 193; ICD10:C73] Phase 1 [524297]
Company
GlobeImmune
Target and Pathway
Target(s) Carcinoembryonic antigen-related cell adhesion molecule 5 Target Info Modulator [551895]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
References
Ref 524297ClinicalTrials.gov (NCT01856920) A Phase 2 Study of GI-6207 in Patients With Recurrent Medullary Thyroid Cancer. U.S. National Institutes of Health.
Ref 551895Clinical pipeline report, company report or official report of GlobeImmune.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.